Skip to content

Clinical trials

Completed Carcinoma, Non-Small-Cell Lung trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Completed Country / region: Hong Kong Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20065
20075
20084
20095
20103
20113
20125
20135
20145
20156
20164
20175
20187
20192
20205
20214
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche12
AstraZeneca8
Pfizer8
Novartis Pharmaceuticals7
Boehringer Ingelheim5
Eisai Inc.3
Genzyme, a Sanofi Company3
Arcus Biosciences, Inc.2
BioAtla, Inc.2
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung78
Lung Neoplasms16
Neoplasms7
Adenocarcinoma4
Carcinoma4
Adenocarcinoma of Lung3
Multiple Endocrine Neoplasia Type 2a3
Brain Neoplasms2
Breast Neoplasms2
Carcinoma, Large Cell2

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.